Medicine and Health
Valnemulin restores colistin sensitivity against multidrug-resistant gram-negative pathogens
C. Xu, Y. Zhang, et al.
This groundbreaking study demonstrates how valnemulin, an FDA-approved drug, can enhance the effectiveness of colistin against resistant gram-negative pathogens. Conducted by Chen Xu, Yuan Zhang, Lingman Ma, and colleagues, the research uncovers the mechanisms of bacterial membrane disruption, leading to cell death—offering hope against multidrug-resistant infections.
~3 min • Beginner • English
Related Publications
Explore these studies to deepen your understanding of the subject.
